Available Across Europe for Online
Sales
VANCOUVER, Aug. 19, 2019 /CNW/ - Harvest One Cannabis
Inc. ("Harvest One" or the "Company") (TSXV: HVT;
OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm
Ltd. ("Satipharm") today announced it has expanded its
product portfolio with the launch of CBD oil, now available online
at www.satipharm.com. Brick and mortar distribution will
follow with major retailers throughout Europe.
The new European oils program has begun with a Lemon & Lime
flavoured CBD oil. Satipharm expects to expand this program with
more varieties in the coming months. Satipharm CBD oils join the
existing CBD Gelpell® capsules, already available across
Europe online and in 1,800 stores
across the UK and Ireland. All of Satipharm's products in
Europe are EU GMP certified to
ensure the highest standards.
The Satipharm Lemon & Lime CBD oil was specifically
formulated to address three major concerns from consumers, which
are taste, GMP certification, and reliable dosage.
"Product innovation is essential to building our brands. Our new
CBD oil illustrates continued movement by Harvest One towards our
strategy of building health, wellness, and self-care brands around
the world," said Grant Froese, Chief
Executive Officer of Harvest One. "Customers can have the same
confidence in new Satipharm CBD oils as they do in our existing
Satipharm CBD Gelpell® already on the market across Europe."
Further to Harvest One's press release dated June 21, 2019 (See SEDAR for full disclosure) in
respect to a shares-for-services agreement, the Company has issued
131,710 common shares at a price of $0.57 per
share.
About Harvest One Cannabis
Harvest One is a global consumer packaged goods company that
develops and distributes premium health, wellness, and lifestyle
products to patients and consumers in regulated markets around the
world. The Company's portfolio of premium products is designed to
enhance quality of life. Shareholders have significant exposure to
the entire cannabis value chain through four wholly-owned
subsidiaries: United Greeneries, a Licensed Producer; Satipharm
(medical and nutraceutical); Dream Water Global and Delivra
(consumer products with an emphasis on sleep, pain, and anxiety),
and a minority interest in Burb Cannabis (retail operations). For
more information, please visit www.harvestone.com.
About Satipharm
Satipharm is a health and wellness company which is specialised
in the development and manufacture of cannabinoid-based products
from the cannabis plant. Our mission is to deliver the highest
quality products that are designed specifically with the needs of
our customers in mind. For more information, please visit
www.satipharm.com.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained in this press release constitute
forward-looking information. These statements relate to future
events or future performance. The use of any of the words "could",
"intend", "expect", "believe", "will", "projected", "estimated" and
similar expressions and statements relating to matters that are not
historical facts are intended to identify forward-looking
information and are based on the Company's current belief or
assumptions as to the outcome and timing of such future events.
Actual future results may differ materially. The forward-looking
information contained in this press release is made as of the date
hereof, and the Company is not obligated to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Because of the risks, uncertainties and
assumptions contained herein, investors should not place undue
reliance on forward-looking information. The foregoing statements
expressly qualify any forward-looking information contained
herein.
Neither TSX-V nor its Regulation Services Provider (as that
term is defined in the policies of the TSX-V) accept responsibility
for the adequacy or accuracy of this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/harvest-one-launches-new-satipharm-cbd-oil-300903425.html
SOURCE Harvest One Cannabis Inc.